182 related articles for article (PubMed ID: 27529090)
21. Second primary breast cancer after unilateral mastectomy alone or with contralateral prophylactic mastectomy.
Agarwal S; Pappas L; Matsen CB; Agarwal JP
Cancer Med; 2020 Nov; 9(21):8043-8052. PubMed ID: 32918537
[TBL] [Abstract][Full Text] [Related]
22. Trends in Contralateral Prophylactic Mastectomy Utilization for Small Unilateral Breast Cancer.
Baskin AS; Wang T; Bredbeck BC; Sinco BR; Berlin NL; Dossett LA
J Surg Res; 2021 Jun; 262():71-84. PubMed ID: 33548676
[TBL] [Abstract][Full Text] [Related]
23. Active Participation in Decision-Making in Contralateral Prophylactic Mastectomy for Patients With Breast Cancer.
Huang J; Chagpar A
J Surg Res; 2019 Oct; 242():129-135. PubMed ID: 31075657
[TBL] [Abstract][Full Text] [Related]
24. Bilateral Mastectomy in Women With Unilateral Breast Cancer: A Review.
Lim DW; Metcalfe KA; Narod SA
JAMA Surg; 2021 Jun; 156(6):569-576. PubMed ID: 33566074
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033).
Davies KR; Brewster AM; Bedrosian I; Parker PA; Crosby MA; Peterson SK; Shen Y; Volk RJ; Cantor SB
Breast Cancer Res; 2016 Sep; 18(1):93. PubMed ID: 27650678
[TBL] [Abstract][Full Text] [Related]
26. The development of a template for psychological assessment of women considering risk-reducing or contralateral prophylactic mastectomy: A national Delphi consensus study.
Braude L; Kirsten L; Gilchrist J; Juraskova I
Psychooncology; 2018 Oct; 27(10):2349-2356. PubMed ID: 29966172
[TBL] [Abstract][Full Text] [Related]
27. Development and pilot testing of a Decision Aid (DA) for women with early-stage breast cancer considering contralateral prophylactic mastectomy.
Ager B; Jansen J; Porter D; Phillips KA; Glassey R; ; Butow P
Breast; 2018 Aug; 40():156-164. PubMed ID: 29857282
[TBL] [Abstract][Full Text] [Related]
28. Streamlining Decision Making in Contralateral Risk-Reducing Mastectomy: Impact of PREDICT and BOADICEA Computations.
de Silva TS; Russell VR; Henry FP; Thiruchelvam PTR; Hadjiminas DJ; Al-Mufti R; Hogben RK; Hunter J; Wood S; Jallali N; Leff DR
Ann Surg Oncol; 2018 Oct; 25(10):3057-3063. PubMed ID: 30019305
[TBL] [Abstract][Full Text] [Related]
29. Operating on Anxiety: Negative Affect toward Breast Cancer and Choosing Contralateral Prophylactic Mastectomy.
Silverstein MC; Lee CN; Scherer LD; Phommasathit C; Merrill AL; Peters E
Med Decis Making; 2023 Feb; 43(2):152-163. PubMed ID: 36059240
[TBL] [Abstract][Full Text] [Related]
30. Contralateral prophylactic mastectomy: A qualitative approach to exploring the decision making process.
Greener JR; Bass SB; Lepore SJ
J Psychosoc Oncol; 2018; 36(2):145-158. PubMed ID: 29064771
[TBL] [Abstract][Full Text] [Related]
31. Surgical Decision-Making Surrounding Contralateral Prophylactic Mastectomy: Comparison of Treatment Goals, Preferences, and Psychosocial Outcomes from a Multicenter Survey of Breast Cancer Patients.
Lizarraga IM; Schroeder MC; Jatoi I; Sugg SL; Trentham-Dietz A; Hoeth L; Chrischilles EA
Ann Surg Oncol; 2021 Dec; 28(13):8752-8765. PubMed ID: 34251554
[TBL] [Abstract][Full Text] [Related]
32. An exploration of Australian psychologists' role in assessing women considering risk-reducing or contralateral prophylactic mastectomy.
Braude L; Laidsaar-Powell R; Gilchrist J; Kirsten L; Juraskova I
Breast; 2017 Apr; 32():105-111. PubMed ID: 28135658
[TBL] [Abstract][Full Text] [Related]
33. Decision-making experiences of breast cancer patients related to contralateral prophylactic mastectomy-a systematic meta-synthesis of qualitative studies.
Zhao B; Yi M; Lyu H; Zhang X; Liu Y; Song X
Support Care Cancer; 2023 Mar; 31(4):214. PubMed ID: 36918480
[TBL] [Abstract][Full Text] [Related]
34. Factors associated with decision to undergo contralateral prophylactic mastectomy versus unilateral mastectomy.
Huang J; Chagpar A
Am J Surg; 2019 Jul; 218(1):170-174. PubMed ID: 30554666
[TBL] [Abstract][Full Text] [Related]
35. Rising Rates of Contralateral Prophylactic Mastectomy as a Treatment for Early-Stage Breast Cancer.
Jerome-DʼEmilia B; Kushary D; Suplee PD
Cancer Nurs; 2019; 42(1):12-19. PubMed ID: 29251681
[TBL] [Abstract][Full Text] [Related]
36. Effect of decision-making resources on satisfaction with decision to undergo contralateral prophylactic mastectomy (CPM).
Huang J; Chagpar A
Am J Surg; 2020 Jun; 219(6):1036-1038. PubMed ID: 31570198
[TBL] [Abstract][Full Text] [Related]
37. Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability.
Scheepens JCC; Veer LV'; Esserman L; Belkora J; Mukhtar RA
Breast; 2021 Apr; 56():61-69. PubMed ID: 33621798
[TBL] [Abstract][Full Text] [Related]
38. Reframing the conversation about contralateral prophylactic mastectomy: Preparing women for postsurgical realities.
Bloom DL; Chapman BM; Wheeler SB; McGuire KP; Lee CN; Weinfurt K; Rosenstein DL; Plichta JK; Jacobson Vann JC; Hwang ES
Psychooncology; 2019 Feb; 28(2):394-400. PubMed ID: 30500102
[TBL] [Abstract][Full Text] [Related]
39. Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey.
Rosenberg SM; Tracy MS; Meyer ME; Sepucha K; Gelber S; Hirshfield-Bartek J; Troyan S; Morrow M; Schapira L; Come SE; Winer EP; Partridge AH
Ann Intern Med; 2013 Sep; 159(6):373-81. PubMed ID: 24042365
[TBL] [Abstract][Full Text] [Related]
40. Does a brief surgeon training in negotiation theory principles decrease rates of contralateral prophylactic mastectomy?
Mamtani A; Sjoberg DD; Vincent A; Ehdaie B; Malhotra D; Vickers A; Morrow M
Breast Cancer Res Treat; 2023 May; 199(1):119-126. PubMed ID: 36881270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
